N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity), 97%, 50mg

PCR plates 24-well 40 pcs

5-(2-furyl)-2H-1,2,6-thiadiazine-3-carboxylic acid 1,1-dioxide, 1g

2-Amino-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one, 97%, 250mg

5-bromo-3-fluoro-2-nitropyridine, 97.0%, 5g

(6-Hydroxymethyl-pyridin-3-yl)-carbamic acid tert-butyl ester, 95.0%, 5g

6-Chloro-n-(prop-2-yn-1-yl)pyridine-3-carboxamide, 95%, 100mg

Phenyl Vinyl Sulfide (stabilized with TBC)>98.0%(GC)5g

(S)-4-N-Boc-2-Hydroxymethyl-piperazine, 97.0%, 25g

Rac-(3r,4s)-4-(4-hydroxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride, 95+%, 100mg

5-Amino-4-(3-methoxyphenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxylic acid, 97%, 100mg

N-Methoxydiacetamide [Selective Acetylating Reagent]>95.0%(GC)5g

(2S)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid, 95%, 10g